Search results
Pieris Pharmaceuticals (PIRS) Loses 41.5% in 4 Weeks, Here's Why a Trend Reversal May be Around the...
Zacks via Yahoo Finance· 2 years agoPieris Pharmaceuticals (PIRS) has become technically an oversold stock now, which implies exhaustion...
Pieris (PIRS) Pursues Strategic Alternatives, Stock Rises
Zacks via Yahoo Finance· 9 months agoPieris Pharmaceuticals’ PIRS shares were up almost 12% on Jul 18, after management announced...
Pieris Pharmaceuticals Full Year 2022 Earnings: US$0.45 loss per share (vs US$0.71 loss in FY 2021)
Simply Wall St. via Yahoo Finance· 1 year agoPieris Pharmaceuticals (NASDAQ:PIRS) Full Year 2022 Results Key Financial Results Revenue: US$25.9m...
Pieris Pharmaceuticals (PIRS) Reports Q1 Loss, Lags Revenue Estimates
Zacks via Yahoo Finance· 2 years agoPieris Pharmaceuticals (PIRS) delivered earnings and revenue surprises of 41.67% and 2.80%,...
How Many Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) Shares Do Institutions Own?
Simply Wall St. via Yahoo Finance· 2 years agoIf you want to know who really controls Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS), then you'll have...
Pieris Pharmaceuticals (NASDAQ:PIRS) shareholders have endured a 81% loss from investing in the...
Simply Wall St. via Yahoo Finance· 1 year agoPieris Pharmaceuticals, Inc. (NASDAQ:PIRS) shareholders will doubtless be very grateful to see the...
Pieris Pharmaceuticals, Inc.'s (NASDAQ:PIRS) Shares Lagging The Industry But So Is The Business
Simply Wall St. via Yahoo Finance· 12 months agoPieris Pharmaceuticals, Inc.'s (NASDAQ:PIRS) price-to-sales (or "P/S") ratio of 2.3x might make it...
One Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) Analyst Is Reducing Their Forecasts For This Year
Simply Wall St. via Yahoo Finance· 2 years agoMarket forces rained on the parade of Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) shareholders today,...
Pieris Pharmaceuticals (PIRS) Upgraded to Strong Buy: Here's What You Should Know
Zacks via Yahoo Finance· 8 months agoPieris Pharmaceuticals (PIRS) might move higher on growing optimism about its earnings prospects,...
Investors Don't See Light At End Of Pieris Pharmaceuticals, Inc.'s (NASDAQ:PIRS) Tunnel And Push...
Simply Wall St. via Yahoo Finance· 4 months agoTo the annoyance of some shareholders, Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) shares are down a...